Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.30M | 26.75M | 54.31M | 54.36M | 36.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.30M | 26.75M | 54.31M | 54.36M | 36.06M |
| Cost of Revenue | 37.68M | 20.89M | 42.33M | 41.77M | 28.55M |
| Gross Profit | 11.61M | 5.86M | 11.98M | 12.59M | 7.51M |
| SG&A Expenses | 11.74M | 6.66M | 18.75M | 18.78M | 14.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.88M | 27.63M | 61.89M | 61.29M | 42.99M |
| Operating Income | -577.00K | -883.00K | -7.58M | -6.93M | -6.93M |
| Income Before Tax | -9.66M | -1.51M | -3.51M | -9.90M | -5.63M |
| Income Tax Expenses | -- | -- | -17.00K | -105.00K | -- |
| Earnings from Continuing Operations | -9.66M | -1.53M | -3.49M | -9.79M | -5.63M |
| Earnings from Discontinued Operations | 67.07M | -- | -- | -- | 3.67M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.42M | -3.74M | -3.49M | -9.79M | -1.95M |
| EBIT | -577.00K | -883.00K | -7.58M | -6.93M | -6.93M |
| EBITDA | -158.00K | 893.00K | -5.89M | -5.40M | -5.65M |
| EPS Basic | 0.70 | -0.05 | -0.04 | -0.12 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.03 | -0.07 | -0.04 |
| EPS Diluted | 0.69 | -0.05 | -0.04 | -0.12 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.03 | -0.07 | -0.04 |
| Average Basic Shares Outstanding | 82.45M | 80.61M | 79.89M | 78.54M | 78.04M |
| Average Diluted Shares Outstanding | 82.45M | 80.61M | 79.89M | 78.54M | 78.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |